Low rates of hepatitis C testing among people who inject drugs in Thailand: Implications for peer-based interventions

Journal of Public Health (United Kingdom)

Volumn 35, Issue 4, 2013, Pages 578-584

  Ti, L ^a,b   Kaplan, K ^c   Hayashi, K ^a,b   Suwannawong, P ^c   Wood, E ^a,b   Kerr, T ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Thai AIDS Treatment Action Group   (Thailand)

Author keywords

Hepatitis C testing; Peer education intervention; People who inject drugs; Thailand

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH PROMOTION; HEPATITIS C; HEPATITIS C TESTING; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PEER GROUP; PEER-EDUCATION INTERVENTION; PEOPLE WHO INJECT DRUGS; PREVALENCE; PSYCHOLOGICAL ASPECT; SEROLOGY; STATISTICS; SUBSTANCE ABUSE; THAILAND;

HEPATITIS C TESTING; PEER-EDUCATION INTERVENTION; PEOPLE WHO INJECT DRUGS; THAILAND;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH PROMOTION; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PEER GROUP; PREVALENCE; SEROLOGIC TESTS; SUBSTANCE ABUSE, INTRAVENOUS; THAILAND;

EID: 84890492814     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fds105     Document Type: Article

References (37)

1. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007;18(5):352-8.
2. World Health Organization. Hepatitis C fact sheet. WHO. 2011. http://www.who.int/mediacentre/factsheets/fs164/en/index.html (16 May 2012, date last accessed).
3. Walsh N, Verster A, Doupe A et al. 3.1. The silent epidemic: responding to viral hepatitis among people who inject drugs. In: Cook C (ed.). Global State of Harm Reduction 2010: Key Issues for Broadening the Response. London: International Harm Reduction Association, 2010.
4. Freeman AJ, Dore GJ, Law MG et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2003;34(4):809-16.
5. Perz JF, Armstrong GL, Farrington LA et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45(4):529-38.
6. Martinez-Sierra C, Arizcorreta A, Diaz F et al. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C Virus and human immunodeficiency virus. Clin Infect Dis 2003;36(4):491-8.
7. Alter M. Epidemiology of viral hepatitis and HIV co-infection. J d Hepatol 2006;44(S1):S6-9.
8. Thai AIDS Treatment Action Group. Training manual for treatment advocates: hepatitis B, Hepatitis C, & coinfection with HIV. Bangkok, 2010. http://www.ttag.info/pdf/TRAINING-MANUAL.pdf (24 December 2012, date last accessed).
9. Piratvisuth T, Pramoolsinsap C, Chutaputti A. Cost-effectiveness analysis of peginterferon alfa-2a (40KD) plus ribavirin versus no treatment in patients with chronic hepatitis C (CHC) genotype 1 from a payer perspective in Thailand. Boston, 2009.
10. Chan K, Stoove M, Sringernyuang L et al. Stigmatization of AIDS patients: disentangling Thai nursing students' attitudes towards HIV/AIDS, drug use, and commercial sex. AIDS Behav 2008;12:146-57.
11. Edlin BR, Kresina TF, Raymond DB et al. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users. Clin Infect Dis 2005;40(s5):S276-85.
12. Myles A, Mugford GJ, Zhao J et al. Physicians' attitudes and practice toward treating injection drug users infected with hepatitis C virus: results from a national specialist survey in Canada. Can J Gastroenterol 2011;25(3):135-9.
13. Hayashi K, Montaner J, Kaplan K et al. Low uptake of hepatitis C testing and high prevalence of risk behavior among HIV-positive injection drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr 2011;56(5):e133-5.
14. Ti L, Hayashi K, Kaplan K et al. HIV testing and willingness to get HIV testing at a peer-run drop-in centre for people who inject drugs in Bangkok, Thailand. BMC Public Health 2012;12:189.
15. Edlin BR. Prevention and treatment of hepatitis C in injection drug users. Hepatology 2002;36(S1):S210-9.
16. Swan D, Long J, Carr O et al. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. AIDS Patient Care and STDs 2010;24(12):753-62.
17. Aitken C, Kerger M, Crofts N. Peer-delivered hepatitis C testing and counselling: a means of improving the health of injecting drug users. Drug Alcohol Rev 2002;21:33-7.
18. Norman J, Walsh N, Mugavin J et al. The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users. Harm Reduct J 2008;5(1):8.
19. Smith P. Thai government in massive campaign to round up drug users. Drug War Chronicle, 2011. http://stopthedrugwar.org/chronicle/2011/feb/23/thai- government-massive-campaign (24 December 2012, date last accessed).
20. Human Rights Watch. Abusing the abuser: police misconduct, harm reduction, and HIV/AIDS in Vancouver. New York: Human Rights Watch, 2003. http://www.hrw.org/reports/2003/canada/canada0503.pdf (24 December 2012, date last accessed).
21. The Global Fund to Fight AIDS, tuberculosis and malaria. Grant Portfolio: Thailand, 2012. http://portfolio.theglobalfund.org/en/Grant/List/THA (24 December 2012, date last accessed).
22. Heathcote J, Main J. Treatment of hepatitis C. J Viral Hepat 2005;12(3):223-35.
23. WHO, UNODC, UNAIDS. WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: WHO, 2009.
24. Broadhead R, Heckathorn D, Anthony D et al. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep 1998;113:42-57.
25. Kerr T, Hayashi K, Fairbairn N et al. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre. Int J Drug Policy 2010;21:255-8.
26. Needle R, Burrows D, Friedman S et al. Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. Int J Drug Policy 2005;16(S1):45-57.
27. Population Services International. PSI: injecting drug users, 2010. http://www.psi.org/our-work/healthy-lives/interventions/injecting-drug-users (24 December 2012, date last accessed).
28. Suwannawong P, Yimchaem W, Ishida T et al. Preventing HIV/AIDS and increasing care and support for injection drug users in Thailand: A user-run project supported by the Global Fund. Bangkok, 2004. http://www.iasociety.org/ Default.aspx?pageId=11&abstractId= 2168924
29. Loughlin AM, Schwartz R, Strathdee SA. Prevalence and correlates of HCV infection among methadone maintenance attendees: implications for HCV treatment. Int J Drug Policy 2004;15(2):93-101.
30. Walley AY, White MC, Kushel MB et al. Knowledge of and interest in hepatitis C treatment at a methadone clinic. J Subst Abuse Treat 2005;28(2):181-7.
31. Wood E, Hogg RS, Kerr T et al. Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users. AIDS 2005;19(8):837-9.
32. Birkhead GS, Klein SJ, Candelas AR et al. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Int J Drug Policy 2007;18(5):417-25.
33. Maek-A-Nantawat W, Avihingsanon A, Ohata PJ. Challenges in providing treatment and care for viral hepatitis among individuals co-infected with HIV in resource-limited settings. AIDS Res Treat 2012;2012:948059.
34. Strauss SM, Astone-Twerell JM, Munoz-Plaza C et al. Hepatitis C knowledge among staff in U.S. drug treatment programs. J Drug Educ 2006;36(2):141-58.
35. Ministry of Public Health Thailand. National guidelines on HIV/AIDS diagnosis and treatment: Thailand 2010, 2010. http://dpc10. ddc.moph.go.th/km55/ aids/ThaiGuidelineonHIVdiagnosisandtreatment 2010.pdf (24 December 2012, date last accessed).
36. Lorvick J, Kral AH, Seal K et al. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health 2001;91(1):46-7.
37. Thorpe LE, Ouellet LJ, Hershow R et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002;155(7):645-53.